Detection of genetic alterations in hereditary colorectal cancer screening
- PMID: 19931546
- DOI: 10.1016/j.mrfmmm.2009.11.002
Detection of genetic alterations in hereditary colorectal cancer screening
Abstract
There are two major hereditary colorectal cancer syndromes: Adenomatous Polyposis, secondary to APC germline alterations (FAP, Familial Adenomatous Polyposis) or secondary to MUTYH germline alterations (MAP, MUTYH associated Polyposis), and Lynch syndrome, associated with germline mutations in mismatch repair genes (MLH1, MSH2, MSH6 and PMS2). The elucidation of their genetic basis has depicted an increasingly complex picture that has lead to the implementation of complex diagnostic algorithms that include both tumor profiling and germline analyses. A variety of techniques at the DNA, RNA and protein level are used to screen for molecular alterations both in tumor biopsies (microsatellite instability analysis, mismatch repair protein immunohistochemistry, BRAF-Val600Glu detection and MLH1 promoter hypermethylation analysis) and in the germline (point mutation screening, copy number assessment). Also functional tests are more often used to characterize variants of unknown significance. Methodological issues associated with the techniques analyzed, as well as the algorithms used, are discussed.
2009 Elsevier B.V. All rights reserved.
Similar articles
-
A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair.Genes Chromosomes Cancer. 2001 Feb;30(2):181-6. Genes Chromosomes Cancer. 2001. PMID: 11135435
-
Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.Hum Mutat. 2006 Oct;27(10):1064. doi: 10.1002/humu.9460. Hum Mutat. 2006. PMID: 16941501
-
Mouse models for colorectal cancer.Oncogene. 1999 Sep 20;18(38):5325-33. doi: 10.1038/sj.onc.1203036. Oncogene. 1999. PMID: 10498885 Review.
-
Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects.Schweiz Med Wochenschr. 1997 Apr 19;127(16):682-90. Schweiz Med Wochenschr. 1997. PMID: 9140167 Review.
-
Molecular biology from bench-to-bedside - which colorectal cancer patients should be referred for genetic counselling and risk assessment.Eur J Cancer. 2010 Jul;46(10):1823-8. doi: 10.1016/j.ejca.2010.03.016. Epub 2010 Apr 21. Eur J Cancer. 2010. PMID: 20417091
Cited by
-
Germline deletions in the EPCAM gene as a cause of Lynch syndrome - literature review.Hered Cancer Clin Pract. 2013 Aug 12;11(1):9. doi: 10.1186/1897-4287-11-9. Hered Cancer Clin Pract. 2013. PMID: 23938213 Free PMC article.
-
Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals.Fam Cancer. 2011 Dec;10(4):641-7. doi: 10.1007/s10689-011-9461-y. Fam Cancer. 2011. PMID: 21681552
-
Genetic predisposition to colorectal cancer: where we stand and future perspectives.World J Gastroenterol. 2014 Aug 7;20(29):9828-49. doi: 10.3748/wjg.v20.i29.9828. World J Gastroenterol. 2014. PMID: 25110415 Free PMC article. Review.
-
Molecular Characterization of Somatic Alterations in Dukes' B and C Colorectal Cancers by Targeted Sequencing.Front Pharmacol. 2017 Jul 18;8:465. doi: 10.3389/fphar.2017.00465. eCollection 2017. Front Pharmacol. 2017. PMID: 28769798 Free PMC article.
-
Microsatellite instability typing in serum and tissue of patients with colorectal cancer: comparing real time PCR with hybridization probe and high-performance liquid chromatography.Mol Biol Rep. 2014 May;41(5):2835-44. doi: 10.1007/s11033-014-3138-1. Epub 2014 Jan 23. Mol Biol Rep. 2014. PMID: 24452720
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous